Posted by Defense World Staff on May 26th, 2024
Vanguard Personalized Indexing Management LLC lifted its holdings in shares of NICE Ltd. (NASDAQ:NICE – Free Report) by 4.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,114 shares of the technology company’s stock after purchasing an additional 89 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in NICE were worth $422,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in the business. GAMMA Investing LLC acquired a new position in NICE in the fourth quarter valued at approximately $25,000. Lindbrook Capital LLC lifted its position in shares of NICE by 88.9% during the 4th quarter. Lindbrook Capital LLC now owns 136 shares of the technology company’s stock valued at $27,000 after acquiring an additional 64 shares during the period. McGlone Suttner Wealth Management Inc. bought a new position in NICE during the fourth quarter worth $29,000. Cary Street Partners Investment Advisory LLC acquired a new stake in NICE in the third quarter worth $37,000. Finally, Principal Securities Inc. bought a new stake in NICE in the fourth quarter valued at $64,000. Institutional investors and hedge funds own 63.34% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have recently commented on NICE shares. StockNews.com upgraded NICE from a “hold” rating to a “buy” rating in a research note on Thursday. Northland Securities started coverage on NICE in a report on Tuesday, January 30th. They issued an “outperform” rating and a $300.00 target price on the stock. Rosenblatt Securities started coverage on shares of NICE in a research report on Tuesday, April 23rd. They issued a “buy” rating and a $285.00 price target for the company. Barclays upped their price objective on shares of NICE from $283.00 to $320.00 and gave the stock an “overweight” rating in a report on Friday, February 23rd. Finally, TheStreet upgraded shares of NICE from a “c+” rating to a “b-” rating in a report on Tuesday, February 6th. Fifteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, NICE currently has a consensus rating of “Buy” and an average target price of $285.92.
Check Out Our Latest Stock Analysis on NICE
NICE Price Performance
NICE stock opened at $189.66 on Friday. The stock has a market cap of $11.92 billion, a P/E ratio of 34.23, a P/E/G ratio of 1.57 and a beta of 1.04. The company has a quick ratio of 2.43, a current ratio of 2.43 and a debt-to-equity ratio of 0.13. The company’s 50 day moving average price is $231.18 and its two-hundred day moving average price is $217.52. NICE Ltd. has a 52 week low of $149.54 and a 52 week high of $270.73.
NICE (NASDAQ:NICE – Get Free Report) last posted its quarterly earnings data on Thursday, February 22nd. The technology company reported $2.36 earnings per share for the quarter, topping the consensus estimate of $2.26 by $0.10. NICE had a return on equity of 14.05% and a net margin of 14.92%. The business had revenue of $623.20 million for the quarter, compared to analysts’ expectations of $616.83 million. During the same quarter in the previous year, the firm earned $1.40 earnings per share. The business’s revenue was up 9.6% on a year-over-year basis. On average, equities analysts predict that NICE Ltd. will post 8.23 earnings per share for the current year.
About NICE
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
Featured Articles
- Five stocks we like better than NICE
- Why Invest in Biotech Stocks
- MarketBeat Week in Review – 5/20 – 5/24
- What Are Dividend Challengers?
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- Profitably Trade Stocks at 52-Week Highs
- These 2 Retail Traders Favorites are Nearing Major Breakouts
Want to see what other hedge funds are holding NICE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NICE Ltd. (NASDAQ:NICE – Free Report).
Receive News & Ratings for NICE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NICE and related companies with MarketBeat.com's FREE daily email newsletter.
You might be interested in:
Vanguard Personalized Indexing Management LLC Cuts Stock Position in monday.com Ltd.
Vanguard Personalized Indexing Management LLC Has $418,000 Stock Holdings in Wynn Resorts, Limited
Vanguard Personalized Indexing Management LLC Has $420,000 Stock Holdings in Balchem Co.
Vanguard Personalized Indexing Management LLC Acquires 89 Shares of NICE Ltd.
Ionis Pharmaceuticals, Inc. Shares Acquired by Vanguard Personalized Indexing Management LLC
Vanguard Personalized Indexing Management LLC Has $426,000 Stake in The Timken Company